Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SLV vs GSK✓SelectedUSD · GSKSLV vs GSK performance historyLatest closeAs of-3.94%11/16
Stock and ETF performance explorer

SLV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+84.6%
GSK return
+46.9%
Excess return
+37.7%
Maximum drawdown
-59.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.9%-0.1%-3.9%-3.9%
7D-11.9%-1.3%-10.6%-11.8%
30D-17.7%+2.7%-20.4%-18.1%
3M-27.5%+2.7%-30.2%-27.9%
6M-38.6%+3.3%-41.9%-39.1%
YTD-34.2%+6.5%-40.7%-35.1%
1Y-7.8%+10.7%-18.4%-9.6%
3Y+94.8%+64.4%+30.5%+72.7%
5Y+84.6%+46.7%+37.9%+57.7%
All+84.6%+46.9%+37.7%+57.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling